• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Neonatal hyperoxia alters the host response to influenza A virus infection in adult mice through multiple pathways

tetano

Editor, Senior Moderator
Am J Physiol Lung Cell Mol Physiol. 2013 Jun 7. [Epub ahead of print]
Neonatal hyperoxia alters the host response to influenza A virus infection in adult mice through multiple pathways.
Buczynski BW, Yee M, Martin KC, Lawrence BP, O'Reilly MA.
Source

1The University of Rochester.
Abstract

Exposing preterm infants or newborn mice to high concentrations of oxygen disrupts lung development and alters the response to respiratory viral infections later in life. Superoxide dismutase (SOD) has been separately shown to mitigate hyperoxia-mediated changes in lung development and attenuate virus-mediated lung inflammation. However, its potential to protect adult mice exposed to hyperoxia as neonates against viral infection is not known. Here, transgenic (Tg) mice over-expressing extracellular (EC)-SOD in alveolar type II epithelial cells are used to test whether SOD can alleviate the deviant pulmonary response to influenza virus infection in adult mice exposed to hyperoxia as neonates. Fibrotic lung disease, observed following infection in wild-type (WT) mice exposed to hyperoxia as neonates, was prevented by over-expression of EC-SOD. However, leukocyte recruitment remained excessive and levels of MCP-1 remained modestly elevated following infection in EC-SOD Tg mice exposed to hyperoxia as neonates. Since MCP-1 is often associated with pulmonary inflammation and fibrosis, the host response to infection was concurrently evaluated in adult Mcp-1 WT and Mcp-1 KO mice exposed to neonatal hyperoxia. In contrast to EC-SOD, excessive leukocyte recruitment, but not lung fibrosis, was dependent upon MCP-1. Our findings demonstrate that neonatal hyperoxia alters the inflammatory and fibrotic responses to influenza A virus infection through different pathways. Therefore, these data suggest that multiple therapeutic strategies may be needed to provide complete protection against diseases attributed to prematurity and early-life exposure to oxygen.
KEYWORDS:

lung fibrosis, monocyte chemoattractant protein, neonatal hyperoxia, respiratory viral infection, superoxide dismutase

PMID:
23748535
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23748535
 
Back
Top Bottom